Use of tigecycline in pediatric clinical practice
Authors:
- 17 April 2017
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 15 (6) , 605-612
Abstract
Introduction: Tigecycline, a derivative of minocycline, is an extended-spectrum antimicrobial agent. It has a restricted approval field in children and the experience of its adoption in clinical practice is reserved for cases of challenging infections. The aim of this review was to summarize evidence regarding the use of tigecycline in infants and children, focusing on the drug’s clinical efficacy data and tolerability profile. Areas covered: We have conducted a literature search of the Cochrane Library, EMBASE, and MEDLINE databases, from their inception through 5 January 2017, using the following terms: tigecycline, newborn, infant, child, pediatrics, adolescent, human, clinical trial, and case report. Articles were excluded if they were redundant or not pertinent. Bibliographies of all relevant articles were also evaluated. Seventeen publications were included: 1 pharmacokinetic study, 16 case reports. In the selected publications, the patients’ mean age was 4.45 years, 38.7% of children was <3 years old and favorable clinical response was achieved in 74.2% of cases. Expert commentary: Tigecycline may be a considerable option in life-threatening infections in pediatric patients. Its administration is well tolerated and has demonstrated a good clinical response in nonbacteremic patients. However, the available clinical records are limited and more studies are needed.Keywords
This publication has 30 references indexed in Scilit:
- Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patientAnnals of Clinical Microbiology and Antimicrobials, 2013
- Pediatric Acute Pancreatitis Related to TigecyclineThe Pediatric Infectious Disease Journal, 2010
- Tigecycline treatment of multi‐drug‐resistant Corynebacterium jeikeium infection in a child with relapsing and refractory acute lymphoblastic leukemiaPediatric Blood & Cancer, 2010
- MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLERThe Pediatric Infectious Disease Journal, 2010
- Tigecycline attenuates staphylococcal superantigen-induced T-cell proliferation and production of cytokines and chemokinesImmunopharmacology and Immunotoxicology, 2009
- Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Tigecycline: A Single Antibiotic for Polymicrobial InfectionsThe Pediatric Infectious Disease Journal, 2007
- Tigecycline: A glycylcycline antimicrobial agentClinical Therapeutics, 2006
- A Novel MATE Family Efflux Pump Contributes to the Reduced Susceptibility of Laboratory-Derived Staphylococcus aureus Mutants to TigecyclineAntimicrobial Agents and Chemotherapy, 2005
- Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1Antimicrobial Agents and Chemotherapy, 2003